Showing results (211-220 of 451) with videos related to

Sort By:
Pageof 46
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1996
Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccinesM Rodolfo, C Zilocchi, C Melani, et al.
Tumori|August 31, 1986
Infusion of autologous alloactivated lymphocytes in melanoma patients: toxicity and immunologic monitoringC Gambacorti-Passerini, R Marolda, G Tona, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytesG Fossati, A Balsari, D Taramelli, et al.
Neuroreport|April 11, 2000
Large-scale identification of differentially expressed genes during neurogenesisC Pazman, J C Castelli, X Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Receptor-mediated uptake of an extracellular Bcl-x(L) fusion protein inhibits apoptosisX H Liu, J C Castelli, R J Youle
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II studyA M Di Giacomo, P A Ascierto, P Queirolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized studyG Pizzocaro, L Piva, M Colavita, et al.
European Journal of Immunology|September 1, 1992
Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: role of ICAM-1 defined by antibody blocking and gene transferN Jonjic, S Alberti, S Bernasconi, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cellsM Radrizzani, M Quaia, B Benedetti, et al.
Pageof 46